The Valley Desk

NCT06714617 · Interventional trial

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Overall registry status Terminated

Phase 1

Conditions Breast Cancer Stage III, Endometrial Neoplasms, Fallopian Tube Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, HER2 Gene Mutation, HER2-positive Metastatic Breast Cancer, Her2-Positive, Non Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Solid Tumor, Adult, Unresectable Breast Carcinoma, Urothelial Carcinoma Bladder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov